|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|
| Current assets: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Prepaid insurance | |||||||
| Bank interest receivable | |||||||
| Total current assets | |||||||
| Deferred offering costs | |||||||
| Investment held in Trust Account | |||||||
| Total Assets | |||||||
| Current liabilities: | |||||||
| Accrued expenses | |||||||
| Accounts payable and accrued expenses | |||||||
| Convertible note payable | |||||||
| Due to related party | |||||||
| Related Party | |||||||
| Total due to related party | |||||||
| Total current liabilities | |||||||
| Deferred underwriting commissions | |||||||
| Deferred underwriting commissions | |||||||
| Total liabilities | |||||||
| Class A ordinary shares, $0.0001 par value; 34,500,000 shares subject to possible redemption at $10.57 and $10.24 per share as on September 30, 2025 and December 31, 2024, respectively. | |||||||
| Shareholders’ Deficit | |||||||
| Ordinary shares, value | |||||||
| Class A Ordinary Shares | |||||||
| Class B Ordinary Shares | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders’ Deficit | |||||||
| Total Liabilities, Commitments and Contingencies, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...